Annual report pursuant to Section 13 and 15(d)

Stock Based Compensation and Other Benefit Plans (Tables)

v3.22.4
Stock Based Compensation and Other Benefit Plans (Tables)
12 Months Ended
Dec. 31, 2022
Stock Based Compensation and Other Benefit Plans  
Weighted Average Assumptions

The fair value of stock options granted during the years ended December 31, 2022 and 2021, was estimated based on the following weighted average assumptions for:

Year Ended December 31, 

 

    

2022

    

2021

 

Dividend yield

 

0

%  

0

%

Expected volatility

 

69

%  

83

%

Risk-free interest rate

 

2.68

%  

0.95

%

Expected term

 

5.64 years

5.66 years

Stock Option Activity

The following table summarizes the Company’s stock option activity for the year ended December 31, 2022.

Weighted

    

Weighted

Average

Average

Aggregate

Exercise

Contractual 

Intrinsic

Number of

Price

Remaining Term

Value

shares

Per Share

(in years)

(in thousands)

Outstanding at January 1, 2022

1,911,177

$

20.64

 

6.33

$

15,103

Granted

 

292,972

 

19.40

 

  

 

  

Exercised

 

(128,811)

 

7.22

 

  

 

  

Forfeited, expired or cancelled

(49,796)

 

64.30

 

  

 

  

Outstanding at December 31, 2022

2,025,542

$

20.24

 

6.10

$

10,804

Exercisable at December 31, 2022

1,718,864

$

19.67

 

5.56

$

10,764

Stock-based Compensation Expense

All stock-based compensation expense is recorded in G&A expense. The following table shows total stock-based compensation expense for stock options and ESPP in the consolidated statements of operations and comprehensive (loss) income (in thousands):

Year Ended December 31, 

    

2022

    

2021

Total stock-based compensation expense included in G&A

$

3,608

$

6,195